A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Name: A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients
Published: 2016
License: Public Domain

Federal Research Institute of Pediatric Hematology, Oncology and Immunology · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

hematopoietic-stem-cell-transplantation

wiskott-aldrich syndrome, hematopoietic stem cell transplantation, graft failure, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Related documents